StonvexLoading…
StonvexStonvexStonvexCore line items from KMX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $25.88B | $19.94B | $14.14B | $7.55B |
Operating Income | $383.43M | $494.11M | $410.23M | $283.13M |
Net Income | $247.29M | $367.97M | $95.38M | $210.38M |
EPS (Diluted) | $1.68 | $2.46 | $2.02 | $1.38 |
Total Assets | $26.37B | $25.56B | $27.08B | $27.39B |
Total Liabilities | $20.48B | $19.50B | $20.88B | $21.10B |
Cash & Equivalents | $122.83M | $204.94M | $540.37M | $262.82M |
Free Cash Flow OCF − CapEx | $1.24B | $1.93B | $816.83M | $162.81M |
Shares Outstanding | 141.80M | 143.06M | 147.67M | 150.58M |